http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022515549-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 |
| filingDate | 2019-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022515549-A |
| titleOfInvention | Pantothenamide analog |
| abstract | The present invention provides compounds having antimalarial activity. More specifically, the present invention provides novel compounds that are analogs of pantothenamide. The pantotenamide analogs of the present invention have particularly low IC50 values for the asexual blood stage of Plasmodium malaria and germline mother cells. Also, the pantothenamide analogs of the present invention are characterized by low hepatic metabolism. Therefore, the pantotenamide analogs of the present invention are particularly suitable for use in the therapeutic and / or prophylactic treatment of protozoan infections in human or animal subjects in need thereof. The present invention further provides therapeutic and / or prophylactic use of pharmaceutical formulations containing pantotenamide analogs, as well as pharmaceutical formulations containing pantotenamide analogs and pantotenamide analogs. |
| priorityDate | 2018-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.